News from veracyte, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Sep 20, 2013, 16:37 ET Veracyte, Inc. Files Registration Statement for Initial Public Offering

Veracyte, Inc. today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a...


Jul 08, 2013, 15:45 ET Veracyte Receives Aetna Coverage for Its Afirma® Gene Expression Classifier for Use in Thyroid Cancer Diagnosis

 Veracyte, Inc., a molecular diagnostics company pioneering the field of molecular cytology, today announced that Aetna, the third largest...


Jun 28, 2013, 14:45 ET Veracyte Completes $28 Million Series C Financing Round With GE Ventures as a New Investor

 Veracyte, Inc., a molecular diagnostics company in the field of molecular cytology, today announced the completion of the final tranche of its...


Apr 17, 2013, 08:15 ET Veracyte Announces That New Study Suggests The Number Of Patients At Risk For Unnecessary Thyroid Surgery Is Likely On The Rise

 A new study shows that the number of patients with thyroid nodules who undergo surgery – increasingly to remove all, rather than part,...


Apr 12, 2013, 08:15 ET Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer

 Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced the appointment of...


Mar 12, 2013, 08:15 ET Veracyte Announces Results of Study Assessing Use of BRAF Mutation Testing With Its Afirma® Gene Expression Classifier

 Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced new study findings...


Mar 08, 2013, 08:15 ET Veracyte Announces UnitedHealthcare Coverage Policy For the Afirma® Gene Expression Classifier

Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced that UnitedHealthcare, one of...


Feb 15, 2013, 08:15 ET New Article in PLOS Currents: Evidence on Genomic Tests Supports Use of Veracyte's Afirma® Gene Expression Classifier to Resolve Ambiguous Thyroid Nodule Biopsies

 Veracyte, Inc. today announced that a new review article published in PLOS Currents: Evidence on Genomic Tests concludes that published...


Jan 07, 2013, 08:15 ET Veracyte Announces That New Guidelines Include Molecular Testing for Indeterminate Thyroid Nodules To Reduce Unnecessary Surgeries

Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced that, for the first time,...


Oct 22, 2012, 08:15 ET Veracyte Announces Publication Of Analytic Validity Study For Its Afirma® Gene Expression Classifier

Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced that study findings...


Aug 29, 2012, 08:15 ET Veracyte Receives New York State License for Afirma® Gene Expression Classifier

Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company (EURONEXT: SAN...


Jul 17, 2012, 10:28 ET New Study Suggests That Use of Veracyte's Afirma® Gene Expression Classifier Helps to Significantly Reduce Surgeries in Patients with Ambiguous Thyroid Nodule Cytology Results

Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company (EURONEXT: SAN...


Jun 25, 2012, 10:30 ET Veracyte Announces Study Results Published Online in New England Journal of Medicine Which Suggest that Its Afirma® Gene Expression Classifier Can Reduce Unnecessary Thyroid Surgeries

 Veracyte, Inc., a molecular diagnostics company that is pioneering the emerging field of molecular cytology, today announced results from a...


Apr 05, 2012, 08:15 ET Richard T. Kloos, M.D., Joins Veracyte as Senior Medical Director

Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced the appointment of Richard T....


Jan 31, 2012, 08:15 ET Veracyte Appoints Mark Spring as Chief Financial Officer

 Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced the appointment of...


Jan 09, 2012, 09:00 ET Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis

     Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today...


Sep 01, 2011, 08:15 ET New Data Suggest Veracyte's Afirma® Gene Expression Classifier Cost-Effectively Resolves Inconclusive Thyroid Nodule FNA Biopsy Results

Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced that new data from researchers...


Sep 15, 2010, 09:00 ET New Data Suggest Veracyte's Molecular Test Improves Accuracy of Thyroid Nodule Diagnosis Using Fine Needle Aspirate (FNA) Samples

Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, announced that initial data from its...